On 12/9/24, Enanta Pharmaceuticals Inc (NASDAQ: ENTA) stock enjoyed a major increase of 11.8%, closing at $8.94. Moreover, this advance was accompanied by exceptionally high trading volume at 454% of normal. The stock has been extremely weak relative to the market over the last nine months but has risen 4.0% during the last week.
Current PriceTarget Research Rating
Enanta Pharmaceuticals has a current Value Trend Rating of F (Lowest Rating). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. Enanta Pharmaceuticals has a poor Appreciation Score of 19 and a very low Power Rating of 5, resulting in the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment